P. Nouyrigat

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

Breast Oncology, Oncology, Early Breast Cancer +6

Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.

Catherine Faucher, Anne‐Gaëlle Le Corroller, Christian Chabannon et al. · PubMed · 1996 · 51 citations

Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer

Jean‐Marc Ferrero, Emmanuel Chamorey, Stéphane Oudard et al. · Cancer · 2006 · 33 citations · Full text

Osteosarcoma with calcified regional lymph nodes

P. Nouyrigat, J.F. Berdah, Bernard Roullet et al. · Pediatric Radiology · 1993 · 16 citations

Bone Imaging, Medicine, Histopathology +3

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

Elsa Curtit, P. Nouyrigat, Nadine Dohollou et al. · European Journal of Cancer · 2011 · 14 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +9